Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H34N2O |
| Molecular Weight | 330.5075 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCN1CCC(CC1)(C(=O)N(C)CC)C2=CC=CC=C2
InChI
InChIKey=TYWUGCGYWNSRPS-UHFFFAOYSA-N
InChI=1S/C21H34N2O/c1-4-6-7-11-16-23-17-14-21(15-18-23,20(24)22(3)5-2)19-12-9-8-10-13-19/h8-10,12-13H,4-7,11,14-18H2,1-3H3
| Molecular Formula | C21H34N2O |
| Molecular Weight | 330.5075 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Sameridine was developed as a compound with both local anesthetic and opioid properties (partial micro-opioid receptor agonist). This drug participated in clinical trials when administered intrathecally to provide anesthesia for surgery and extended postoperative analgesia. However, further development of this drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Hypercarbic and hypoxic ventilatory responses after intrathecal administration of bupivacaine and sameridine. | 2003-02 |
|
| Novel local anaesthetics and novel indications for local anaesthetics. | 2001-12 |
|
| Determination of sameridine in blood plasma by nitrogen-selective gas chromatography. | 2001-08-25 |
|
| The effects on hypercarbic ventilatory response of sameridine compared to morphine and placebo. | 2001-02 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12538214
Twenty-four healthy volunteers received either 25 mg of sameridine or 15 mg of bupivacaine intrathecally. Ventilation was measured by pneumotachography and in-line capnography
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:38 GMT 2025
by
admin
on
Mon Mar 31 18:16:38 GMT 2025
|
| Record UNII |
NQP2Y50Y6B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID30162367
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
C72174
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104504
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
SAMERIDINE
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
NQP2Y50Y6B
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
143257-97-0
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
SUB10436MIG
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
100000080549
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
7050
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
C113809
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY | |||
|
65996
Created by
admin on Mon Mar 31 18:16:38 GMT 2025 , Edited by admin on Mon Mar 31 18:16:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET->PARTIAL AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|